2023-05 |
NMDA receptor glycine binding site modulators for prevention and treatment of ketamine use disorder |
article |
web page(172) |
2022-11 |
Beneficial effects of atypical antipsychotics on object recognition deficits after adolescent toluene exposure in mice: involvement of 5-HT1A receptors |
article |
web page(158) |
2022-11 |
L-4-Fluorophenylglycine produces antidepressant-like effects and enhances resilience to stress in mice |
article |
web page(243) |
2021-12 |
Betaine prevents and reverses the behavioral deficits and synaptic dysfunction induced by repeated ketamine exposure in mice |
article |
web page(244) |
2021-10 |
Betaine supplementation to rats alleviates disturbances induced by high-fat diet: pleiotropic effects in model of type 2 diabetes |
article |
web page(195) |
2021-09 |
N, N-dimethylglycine Protects Behavioral Disturbances and Synaptic Deficits Induced by Repeated Ketamine Exposure in Mice |
article |
web page(177) |
2021-07 |
Differential inhibitory effects of resveratrol on excitotoxicity and synaptic plasticity: involvement of NMDA receptor subtypes |
article |
pdf(207) |
2020-12 |
Increased behavioral and neuronal responses to a hallucinogenic drug after adolescent toluene exposure in mice: effects of antipsychotic treatment |
article |
pdf(239) |
2020-12 |
N,Ndimethylglycine prevents toluene-induced impairment in recognition memory and synaptic plasticity in mice |
article |
pdf(233) |
2020-06 |
Effectiveness in the block by honokiol. A dimerized allylphenol from Magnonia officinalis, of Hyperpolarization-activated cation current and delayed-rectifier K current |
article |
pdf(205) |
2018-12 |
Therapeutic effects of honokiol on motor impairment in hemiparkinsonian mice are associated with reversing neurodegeneration and targeting PPARr regulation |
article |
pdf(479) |
2018-09 |
Attenuation of toluene-induced brain stimulation reward enhancement and behavioral disturbances by N-acetylcysteine in mice |
article |
pdf(598) |
2018-08 |
Protective and therapeutic activity of honokiol in reversing motor deficits and neuronal degeneration in the mouse model of Parkinson’s disease |
article |
pdf(433) |
2018-08 |
Lamotrigine attenuates the motivation to self-administer ketamine and prevents cue- and prime-induced reinstatement of ketamine-seeking behavior in rats |
article |
pdf(469) |
2018 |
Protective and therapeutic activity of honokiol in reversing motor deficits and neuronal degeneration in the mouse model of Parkinson’s disease |
article |
pdf(563) |
2018 |
Distinct effects of resveratrol on seizures and hyperexcitability induced by NMDA and 4-aminopyridine |
article |
web page(1121) |
2017-12 |
Effect of Pachybasin on General Toxicity and Developmental Toxicity in Vivo |
article |
web page(912) |
2017-03 |
Quantitative analysis of the therapeutic effect of magnolol on MPTP-induced mouse model of Parkinson`s disease using in vivo18 F-9-fluoropropyl-(+)-dihydrotetrabenazine PET imaging |
article |
pdf(506) |
2017-03 |
Quantitative analysis of the therapeutic effect of magnolol on MPTP-induced mouse model of Parkinson’s disease using in vivo 18F-9-fluoropropyl-(+)-dihydrotetrabenazine PET imaging. |
article |
pdf(543) |
2017 |
Stimulatory actions of a novel thiourea derivative on large-conductance, calcium-activated potassium channels |
article |
web page(953) |
2017 |
Effects of sarcosine and N, N-dimethylglycine on NMDA receptor-mediated excitatory field potentials |
article |
pdf(899) |
2016-11 |
N,N-dimethylglycine differentially modulates psychotomimetic and antidepressant-like effects of ketamine in mice |
article |
pdf(468) |
2016-10 |
Extracellular calcium concentration and channel activity involved in aminoglycoside-induced hair cell toxicity in the zebrafish lateral line |
article |
pdf(606) |
2016-10 |
Acute and subchronic effects of antipsychotic drugs on cognitive and social deficits after adolescent toluene exposure in mice |
article |
pdf(511) |
2016-09 |
Betaine enhances antidepressant-like, but blocks psychotomimetic effects of ketamine in mice |
article |
pdf(626) |